| ［1］ |
Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities［J］. Br J Dermatol, 2010,162（4）:843⁃847. doi: 10.1111/j.1365⁃2133. 2010.09640.x.
|
| ［2］ |
Nyholt DR, Gillespie NA, Heath AC, et al. Genetic basis of male pattern baldness［J］. J Invest Dermatol, 2003,121（6）:1561⁃1564. doi: 10.1111/j.1523⁃1747.2003.12615.x.
|
| ［3］ |
Pirastu N, Joshi PK, de Vries PS, et al. GWAS for male⁃pattern baldness identifies 71 susceptibility loci explaining 38 of the risk［J］. Nat Commun, 2017,8（1）:1584. doi: 10.1038/s41467⁃017⁃01490⁃8.
|
| ［4］ |
Liu F, Hamer MA, Heilmann S, et al. Prediction of male⁃pattern baldness from genotypes［J］. Eur J Hum Genet, 2016,24（6）:895⁃902. doi: 10.1038/ejhg.2015.220.
|
| ［5］ |
Marcińska M, Pospiech E, Abidi S, et al. Evaluation of DNA variants associated with androgenetic alopecia and their potential to predict male pattern baldness［J/OL］. PLoS One, 2015,10（5）:e0127852. ［2018⁃03⁃10］. https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0127852. doi: 10.1371/journal.pone.0127852.
|
| ［6］ |
Yim E, Nole KL, Tosti A. 5α⁃Reductase inhibitors in androgenetic alopecia［J］. Curr Opin Endocrinol Diabetes Obes,2014,21（6）:493⁃498. doi: 10.1097/MED.0000000000000112.
|
| ［7］ |
Azzouni F, Godoy A, Li Y, et al. The 5 alpha⁃reductase isozyme family: a review of basic biology and their role in human diseases［J］. Adv Urol, 2012,2012:530121. doi: 10.1155/2012/530121.
|
| ［8］ |
Sawaya ME, Price VH. Different levels of 5 alpha⁃reductase type I and II, aromatase, and androgen receptor in hair follicles of women and men with androgenetic alopecia［J］. J Invest Dermatol, 1997,109（3）:296⁃300.
|
| ［9］ |
Lee MJ, Cha HJ, Lim KM, et al. Analysis of the microRNA profile of normal human dermal papilla cells treated with 5α⁃dihydrotestosterone［J］. Mol Med Rep, 2015,12（1）:1205⁃1212. doi: 10.3892/mmr.2015.3478.
|
| ［10］ |
Zhao J, Harada N, Okajima K. Dihydrotestosterone inhibits hair growth in mice by inhibiting insulin⁃like growth factor⁃I production in dermal papillae［J］. Growth Horm IGF Res, 2011,21（5）:260⁃267. doi: 10.1016/j.ghir.2011.07.003.
|
| ［11］ |
Headington JT. Transverse microscopic anatomy of the human scalp. A basis for a morphometric approach to disorders of the hair follicle［J］. Arch Dermatol, 1984,120（4）:449⁃456.
|
| ［12］ |
Jahoda CA. Cellular and developmental aspects of androgenetic alopecia［J］. Exp Dermatol, 1998,7（5）:235⁃248.
|
| ［13］ |
Sinclair R, Torkamani N, Jones L. Androgenetic alopecia: new insights into the pathogenesis and mechanism of hair loss［J］. F1000Res, 2015,4（F1000 Faculty Rev）:585. doi: 10.12688/f1000 research.6401.1.
|
| ［14］ |
Futterweit W, Dunaif A, Yeh HC, et al. The prevalence of hyperandrogenism in 109 consecutive female patients with diffuse alopecia［J］. J Am Acad Dermatol, 1988,19（5 Pt 1）:831⁃836.
|
| ［15］ |
Schmidt JB, Lindmaier A, Trenz A, et al. Hormone studies in females with androgenic hairloss［J］. Gynecol Obstet Invest, 1991,31（4）:235⁃239. doi: 10.1159/000293166.
|
| ［16］ |
Levy LL, Emer JJ. Female pattern alopecia: current perspec⁃tives［J］. Int J Womens Health, 2013,5:541⁃556.
|
| ［17］ |
Sánchez P, Serrano⁃Falcón C, Torres JM, et al. 5α⁃Reductase isozymes and aromatase mRNA levels in plucked hair from young women with female pattern hair loss［J］. Arch Dermatol Res, 2018,310（1）:77⁃83. doi: 10.1007/s00403⁃017⁃1798⁃0.
|
| ［18］ |
Miller JA, Darley CR, Karkavitsas K, et al. Low sex⁃hormone binding globulin levels in young women with diffuse hair loss［J］. Br J Dermatol, 1982,106（3）:331⁃336.
|
| ［19］ |
Zhang Y, Xu J, Jing J, et al. Serum levels of androgen⁃associated hormones are correlated with curative effect in androgenic alopecia in young men［J］. Med Sci Monit, 2018,24:7770⁃7777. doi: 10.12659/MSM.913116.
|
| ［20］ |
Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia［J］. J Am Acad Dermatol, 1993,28（5 Pt 1）:755⁃763.
|
| ［21］ |
Ramos PM, Brianezi G, Martins AC, et al. Apoptosis in follicles of individuals with female pattern hair loss is associated with perifollicular microinflammation［J］. Int J Cosmet Sci, 2016,38（6）:651⁃654. doi: 10.1111/ics.12341.
|
| ［22］ |
Piérard⁃Franchimont C, De Doncker P, Cauwenbergh G, et al. Ketoconazole shampoo: effect of long⁃term use in androgenic alopecia［J］. Dermatology, 1998,196（4）:474⁃477. doi: 10.1159/000017954.
|
| ［23］ |
Aldhalimi MA, Hadi NR, Ghafil FA. Promotive effect of topical ketoconazole, minoxidil, and minoxidil with tretinoin on hair growth in male mice［J］. ISRN Pharmacol, 2014,2014:575423. doi: 10.1155/2014/575423.
|
| ［24］ |
Mahé YF, Michelet JF, Billoni N, et al. Androgenetic alopecia and microinflammation［J］. Int J Dermatol, 2000,39（8）:576⁃584.
|
| ［25］ |
Sadgrove NJ. The new paradigm for androgenetic alopecia and plant⁃based folk remedies: 5α⁃reductase inhibition, reversal of secondary microinflammation and improving insulin resistance［J］. J Ethnopharmacol, 2018,227:206⁃236. doi: 10. 1016/j.jep. 2018.09.009.
|
| ［26］ |
Su LH, Chen LS, Chen HH. Factors associated with female pattern hair loss and its prevalence in Taiwanese women: a community⁃based survey［J］. J Am Acad Dermatol, 2013,69（2）:e69⁃e77. doi: 10.1016/j.jaad.2012.09.046.
|
| ［27］ |
Nargis T, Bejai V, Pinto M, et al. Early onset androgenetic alopecia in men and associated risk factors: a hospital based study［J］. Int J Res Dermatol, 2017,3（2）:267⁃271. doi: 10.18203/ issn.2455⁃4529.IntJResDermatol20172209.
|
| ［28］ |
Yang CC, Hsieh FN, Lin LY, et al. Higher body mass index is associated with greater severity of alopecia in men with male⁃pattern androgenetic alopecia in Taiwan: a cross⁃sectional study［J］. J Am Acad Dermatol, 2014,70（2）:297⁃302.e1. doi: 10.1016/ j.jaad.2013.09.036.
|
| ［29］ |
Fortes C, Mastroeni S, Mannooranparampil TJ, et al. The combination of overweight and smoking increases the severity of androgenetic alopecia［J］. Int J Dermatol, 2017,56（8）:862⁃867. doi: 10.1111/ijd.13652.
|
| ［30］ |
Bittencourt C, Teixeira F, Ferraro DA, et al. Non⁃invasive method distinguishes chronic telogen effluvium from mild female pattern hair loss: clinicopathological correlation［J］. Int J Dermatol, 2016,55（7）:e373⁃e379. doi: 10.1111/ijd.13200.
|
| ［31］ |
Iorizzo M, Tosti A. Treatments options for alopecia［J］. Expert Opin Pharmacother, 2015,16（15）:2343⁃2354. doi: 10.1517/1465 6566.2015.1084501.
|
